Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Microba Life Sciences's Enterprise Value is A$53.94 Mil.
Microba Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.49 Mil. Therefore, Microba Life Sciences's EV-to-EBIT ratio for today is -2.92.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Microba Life Sciences's Enterprise Value is A$53.94 Mil.
Microba Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-16.55 Mil. Therefore, Microba Life Sciences's EV-to-EBITDA ratio for today is -3.26.
Microba Life Sciences Enterprise Value Historical Data
The historical data trend for Microba Life Sciences's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Microba Life Sciences Enterprise Value Chart
Microba Life Sciences Annual Data
Trend
Jun22
Jun23
Enterprise Value
28.89
78.49
Microba Life Sciences Semi-Annual Data
Dec21
Jun22
Dec22
Jun23
Dec23
Enterprise Value
-
28.89
79.15
78.49
53.94
Competitive Comparison of Microba Life Sciences's Enterprise Value
For the Diagnostics & Research subindustry, Microba Life Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microba Life Sciences's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Microba Life Sciences's Enterprise Value falls into.
Microba Life Sciences Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Microba Life Sciences's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences (ASX:MAP) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Microba Life Sciences's current Enterprise Value is A$53.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.49 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Microba Life Sciences's EV-to-EBITDA for today is:
Microba Life Sciences's current Enterprise Value is A$53.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-16.55 Mil.
Microba Life Sciences's current Enterprise Value is A$53.94 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$6.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences Enterprise Value Related Terms
Thank you for viewing the detailed overview of Microba Life Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Microba Life Sciences (ASX:MAP) Business Description
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:MAP has been successfully added to your